MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 75 filers reported holding MAGENTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $441,383 | -4.6% | 582,300 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $462,754 | +101.2% | 582,300 | 0.0% | 0.00% | +200.0% |
| Q4 2022 | $230,009 | -72.0% | 582,300 | 0.0% | 0.00% | -80.0% |
| Q3 2022 | $821,000 | +17.5% | 582,300 | 0.0% | 0.01% | -54.5% |
| Q2 2022 | $699,000 | +109.3% | 582,300 | +1205.8% | 0.01% | +175.0% |
| Q2 2020 | $334,000 | -66.2% | 44,595 | -53.7% | 0.00% | -42.9% |
| Q3 2019 | $987,000 | -53.4% | 96,217 | -33.0% | 0.01% | -66.7% |
| Q2 2019 | $2,117,000 | +1063.2% | 143,544 | +1199.4% | 0.02% | +950.0% |
| Q1 2019 | $182,000 | -82.6% | 11,047 | -94.0% | 0.00% | -88.9% |
| Q4 2018 | $1,043,000 | -69.4% | 183,035 | -35.6% | 0.02% | -45.5% |
| Q3 2018 | $3,412,000 | -27.8% | 284,124 | -18.8% | 0.03% | -13.2% |
| Q2 2018 | $4,725,000 | – | 350,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 6,758,204 | $49,200,000 | 11.16% |
| Aquilo Capital Management, LLC | 3,155,082 | $22,969,000 | 4.17% |
| GREAT POINT PARTNERS LLC | 1,170,000 | $8,518,000 | 1.98% |
| Casdin Capital, LLC | 3,901,589 | $28,404,000 | 0.71% |
| Alphabet Inc. | 3,339,138 | $24,309,000 | 0.58% |
| Bleichroeder LP | 434,400 | $3,162,000 | 0.51% |
| Palo Alto Investors LP | 432,300 | $3,147,000 | 0.19% |
| Integral Health Asset Management, LLC | 90,000 | $655,000 | 0.19% |
| Orbimed Advisors | 1,892,953 | $13,781,000 | 0.15% |
| HARVARD MANAGEMENT CO INC | 332,610 | $2,421,000 | 0.14% |